Tamoxifen Citrate 20 mg/tab – US Stock

$16.38

Tamoxifen Citrate 20 mg/tab from Hilma Biocare is an oral tablet formulation containing 20 mg of tamoxifen citrate per tablet. It belongs to the selective estrogen receptor modulator (SERM) class and is supplied in a 50-tablet pack. This product is available as US Stock.

Product Protected
This product is protected by Hilma Biocare™ Verification
Category:
Description

Tamoxifen Citrate 20 mg/tab – US Stock

Tamoxifen Citrate 20 mg/tab from Hilma Biocare contains 20 mg of tamoxifen citrate per tablet and is supplied in a 50-tablet pack. Tamoxifen citrate belongs to the selective estrogen receptor modulator (SERM) class and has both estrogen-antagonist and estrogen-agonist activity in different tissues.

Product Overview

Tamoxifen citrate is the active ingredient in this Hilma Biocare oral tablet formulation. The supplied product information classifies it as a selective estrogen receptor modulator and antiestrogen.

The source material states that tamoxifen was introduced in 1961 and describes its established pharmaceutical history, including use in breast cancer treatment and other estrogen-receptor-related conditions.

Product Specifications

Specification Details
Brand Hilma Biocare
Active Ingredient Tamoxifen citrate
Strength 20 mg per tablet
Form Oral tablet
Pack Size 50 tablets
Group Selective estrogen receptor modulator (SERM) / Antiestrogen
Subgroup Oral/tablets
Active Half-Life Approximately 5–7 days
Water Retention No
Aromatization No
Stock US Stock

Product Characteristics

Tamoxifen citrate is a selective estrogen receptor modulator with a pharmacological profile that includes both estrogen-antagonist and estrogen-agonist activity depending on the tissue.

According to the supplied information, tamoxifen citrate has a long history of pharmaceutical use and has been associated with the treatment of breast cancer and other conditions involving estrogen receptors. The source material also notes its classification within the SERM group.

The supplied specifications indicate that the product does not retain water and is non-aromatizing.

About Hilma Biocare USA

Hilma Biocare USA supplies this Tamoxifen Citrate 20 mg/tablet formulation as part of the Hilma Biocare product range. Each pack contains 50 oral tablets, with 20 mg of tamoxifen citrate per tablet.

Important Information

Tamoxifen citrate is a pharmacologically active selective estrogen receptor modulator. The supplied information identifies possible adverse reactions including headache, insomnia, nausea, gastrointestinal disorders, fatigue, and leg cramps.

This product information does not constitute personalized medical advice or a recommendation for self-medication. No dosing, cycling, stacking, or performance-enhancement protocol is provided here. Individual use, suitability, interactions, contraindications, and appropriate monitoring should be assessed by an appropriately qualified healthcare professional.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Tamoxifen Citrate 20 mg/tab – US Stock”

Your email address will not be published. Required fields are marked *